MPRINT Translational Research Resource Platform (TRRP) (U24 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications from organizations to establish Translational Research Resource Platforms (TRRPs) that will facilitate, support, and conduct therapeutic-focused research for maternal and pediatric populations. As part of the Maternal and Pediatric Precision in Therapeutics (MPRINT) program this FOA will focus on resource platforms to support concerted multidisciplinary team science efforts that leverage existing and prospective resources (biobanks, biological sample repositories, omics data, tissue specific genomic/epigenomic atlases, EHRs, etc.) to develop innovative technologies and analytic tools that can advance therapeutic research for maternal and pediatric precision therapeutics.

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.